rs1036819

This is a intron variant variant in the ZFAT gene.

GWAS Catalog Trait Associations (1)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

Research that mentions this SNP (2)

Identification of pelvic organ prolapse risk susceptibility gene SNP locus in Xinjiang women
AssociationN=196Aibibuhan· Abulaizi et al.(2020)· International Urogynecology Journal

Candidate gene association study in Xinjiang women identifying pelvic organ prolapse (POP) susceptibility loci. Among 88 POP cases and 108 controls, ESR1 rs17847075 (OR=2.738, P=0.041) and rs2234693 (OR=2.99, P=0.024), ZFAT rs1036819 (OR=10.286, P=0.036), and protective FBLN5 rs12589592 (OR=0.111, P=0.029) showed significant associations with POP risk.

Traits studied:Pelvic organ prolapse
Collagen XVIII and LOXL-4 polymorphisms in women with and without advanced pelvic organ prolapse
AssociationN=532Renata G. M. dos Santos et al.(2018)· International Urogynecology Journal

A case-control study of 532 postmenopausal Brazilian women examining rs2236479 (COL18A1) and rs2862296 (LOXL-4) polymorphisms for association with advanced pelvic organ prolapse (POP). No significant associations were found between either polymorphism and POP (COL18A1 AA: OR=0.69, 95% CI 0.41-1.17; LOXL-4 GG: OR=0.76, 95% CI 0.43-1.35). Age (OR=1.10), number of vaginal deliveries (OR=1.66), and family history (OR=2.55) were identified as independent risk factors for POP.

Traits studied:Pelvic organ prolapseUrinary incontinence

About ZFAT

This gene encodes a protein that likely binds DNA and functions as a transcriptional regulator involved in apoptosis and cell survival. This gene resides in a susceptibility locus for autoimmune thyroid disease (AITD) on chromosome 8q24. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Nov 2009]

View all ZFAT variants →

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…